Physician profile
Stephen Scrivani
NPI 1720088081
$7,002.99
in general payments reported to CMS, 2019-2025
46 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,193 · 2020: $611 · 2021: $1,302 · 2022: $1,243 · 2023: $1,164 · 2024: $1,088 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,653.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $936.51 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $669.73 | 2019-2025 | Jardiance, Ofev, Stiolto Respimat |
| Pfizer INC. | $460.69 | 2019-2025 | |
| Novo Nordisk INC | $457.71 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $452.49 | 2019-2024 | Farxiga, Airsupra |
| Merck Sharp & Dohme LLC | $435.87 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $338.59 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $307.75 | 2019-2023 | Ubrelvy, Synthroid, Viberzi |
| Janssen Pharmaceuticals, INC | $301.01 | 2019-2022 | |
| Exact Sciences Corporation | $276.11 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $263.68 | 2019-2023 | Veozah |
| Amarin Pharma, INC. | $216.92 | 2019-2022 | |
| Amgen INC. | $196.29 | 2019-2025 | Prolia, Evenity, Otezla |
| Sanofi-Aventis U.S. LLC | $187.98 | 2019-2023 | |
| Abbott Laboratories | $185.59 | 2019-2025 | Freestyle Libre 3 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Scrivani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.